Back
Alaunos Therapeutics Quote, Financials, Valuation and Earnings
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade
Sell
20
TCRT
Alaunos Therapeutics
Last Price:
2.13
Seasonality Move:
11.68%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!Alaunos Therapeutics Price Quote
$2.13
+0.12 (+6.01%)
(Updated: November 5, 2024 at 11:40 AM ET)
Alaunos Therapeutics Key Stats
Sell
20
Alaunos Therapeutics (TCRT)
is a Sell
Day range:
$2.00 - $2.04
52-week range:
$2.00 - $32.85
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.85%
Volume:
5.3K
Avg. volume:
19.4K
1-year change:
-82.44%
Market cap:
$3.2M
Revenue:
$5K
EPS:
$-12.71
How Much Does Alaunos Therapeutics Make?
Data Unavailable
Is Alaunos Therapeutics Growing As A Company?
-
What Is Alaunos Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0% -
What Is Alaunos Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Alaunos Therapeutics Stock Price Performance
-
Did Alaunos Therapeutics Stock Go Up Last Month?
Alaunos Therapeutics share price went down by -23.6% last month -
Did TCRT's Share Price Rise Over The Last Year?
TCRT share price fell by -82.44% over the past 1 year
What Is Alaunos Therapeutics 52-Week High & Low?
-
What Is Alaunos Therapeutics’s 52-Week High Share Price?
Alaunos Therapeutics has traded as high as $32.85 over the past 52 weeks -
What Is Alaunos Therapeutics’s 52-Week Low Share Price?
Alaunos Therapeutics has traded as low as $2.00 over the past 52 weeks
Alaunos Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Alaunos Therapeutics?
-
How Much Debt Does Alaunos Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Alaunos Therapeutics Have?
Cash and short term investments quarterly total is $2.5M -
What Is Alaunos Therapeutics’s Book Value Per Share?
Book value per share is 2.36
Is Alaunos Therapeutics Cash Flow Positive?
-
What Is TCRT Cash Flow From Operations?
Cash flow from operations (TTM) is -$17.4M -
What Is Alaunos Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $0 -
What Is Alaunos Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $1.5M
Alaunos Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
TCRT return on invested capital is -189.69% -
What Is Alaunos Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -144.17% -
What Is TCRT Return On Equity?
ROE is a measure of profitability and is -189.69%
Alaunos Therapeutics Earnings Date & Stock Price
-
What Is Alaunos Therapeutics's Stock Price Today?
A single share of TCRT can be purchased today for 2.01 -
What Is Alaunos Therapeutics’s Stock Symbol?
Alaunos Therapeutics trades on the nasdaq under the ticker symbol: TCRT -
When Is Alaunos Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Alaunos Therapeutics is scheduled on November 14, 2024 -
When Is TCRT's next ex-dividend date?
Alaunos Therapeutics's next ex-dividend date is November 5, 2024 -
How To Buy Alaunos Therapeutics Stock?
You can buy Alaunos Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Alaunos Therapeutics Competitors
-
Who Are Alaunos Therapeutics's Competitors?
Below is a list of companies who compete with Alaunos Therapeutics or are related in some way:
Alaunos Therapeutics Dividend Yield
-
What Is TCRT Dividend Yield?
Alaunos Therapeutics’s dividend yield currently is 0% -
What Is Alaunos Therapeutics’s Payout Ratio?
Alaunos Therapeutics’s payout ratio is 0% -
When Did Alaunos Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 5, 2024 -
What Is Alaunos Therapeutics’s Dividend Per Share?
Alaunos Therapeutics pays a dividend of $0.00 per share
Alaunos Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -279.87% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 205.50 |
| Upside from Last Price: | 10127.44% |